stem cell companies closing the valuation gap., page-7

4 million traded in first hour.


Buyers are at this like a mesenchymoangioblast on a damaged limb.


Will it break 3c?

The science is there. Mr Slukvin is very clever.

Clever science with the other clever marketing chaps we seem to have picked up, may make this a winner.


Speculative and complex science, but this seems to be the first company to get in on this type of regenerative cell.

What happens if it works on people like it does on the poor old mouse?

And they can sell it?